- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 22, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article appearing in Nashville Medical News and shared by Tennessee Oncology and OneOncology, titled “The Oncology Care Model Value Proposition,” highlighted 2 meetings, Patient-Centered Oncology Care® in Philadelphia, Pennsylvania, and the Institute for Value-Based Medicine® (IVBM) in Nashville, Tennessee, conducted by The American Journal of Managed Care® (AJMC®). The article spotlighted the presentation of featured IVBM speaker Stephen Schleicher, MD, MBA, physician and Tennessee Oncology’s chair of the Quality and Value Committee at OneOncology.
Endpoints News referenced an article from AJMC®’s sister site, The Center for Biosimilars®, titled “AbbVie and Boehringer Ingelheim Settle Over Biosimilar Adalimumab.” The article detailed the announcement of AbbVie's patent litigation settlement with Boehringer Ingelheim over the biosimilar Cyltezo, which references AbbVie’s originator adalimumab, Humira.
Another article from The Center for Biosimilars® was also featured in the November 18, 2019 daily regulatory news and intelligence briefing from Regulatory Focus. The article, “Biosimilars Make Progress in the Canadian Market, but Stakeholders See More Work Ahead,” was included in the In Focus: International section. The article emphasized strides made by Canada in its biosimilar experience.
An article in Williston Herald, “A New Way to Fight Breast Cancer,” highlighted an AJMC® article, “FDA Approves First Breast Cancer Drug to Target PIK3CA Mutation Plus Companion Diagnostic Test.” The article covered the announcement by the FDA of the approval for the novel oral drug alpelisib, sold as Piqray.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
